Earnings NewsHealthcareMedgenics FY14 resultsFeb. 13, 2015 8:29 AM ETAevi Genomic Medicine, LLC (GNMX) StockBy: SA News Team Medgenics (MDGN +0.1%) FY14 results: Revenues: $0; R&D Expense: $8.6M (+17.8%); SG&A: $10.7M (+1.9%); Operating Loss: ($18.9M) (-6.2%); Net Loss: ($18.4M) (-7.6%); Loss Per Share: ($1.00) (+5.7%); Quick Assets: $33.3M (+48.7%). No guidance given. Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgGNMX--Aevi Genomic Medicine, LLCTrending AnalysisTrending News